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REVIEW
Multi-omic data integration and analysis 
using systems genomics approaches: methods 
and applications in animal production, health 
and welfare
Prashanth Suravajhala†, Lisette J. A. Kogelman† and Haja N. Kadarmideen*†
Abstract 
In the past years, there has been a remarkable development of high-throughput omics (HTO) technologies such as 
genomics, epigenomics, transcriptomics, proteomics and metabolomics across all facets of biology. This has spear-
headed the progress of the systems biology era, including applications on animal production and health traits. How-
ever, notwithstanding these new HTO technologies, there remains an emerging challenge in data analysis. On the one 
hand, different HTO technologies judged on their own merit are appropriate for the identification of disease-causing 
genes, biomarkers for prevention and drug targets for the treatment of diseases and for individualized genomic pre-
dictions of performance or disease risks. On the other hand, integration of multi-omic data and joint modelling and 
analyses are very powerful and accurate to understand the systems biology of healthy and sustainable production of 
animals. We present an overview of current and emerging HTO technologies each with a focus on their applications 
in animal and veterinary sciences before introducing an integrative systems genomics framework for analysing and 
integrating multi-omic data towards improved animal production, health and welfare. We conclude that there are big 
challenges in multi-omic data integration, modelling and systems-level analyses, particularly with the fast emerging 
HTO technologies. We highlight existing and emerging systems genomics approaches and discuss how they con-
tribute to our understanding of the biology of complex traits or diseases and holistic improvement of production 
performance, disease resistance and welfare.
© 2016 Suravajhala et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Finding causal and regulatory gene variants and using 
predictive genetic markers or biomarkers for complex 
diseases and traits constitute a major baseline for all fac-
ets of genomics, including livestock genomics. Genome-
wide association studies (GWAS) have provided useful 
insights into the genetic architecture of complex diseases 
and traits in the form of potential causal single nucleotide 
polymorphisms (SNPs), structural variants and candidate 
genes. Nevertheless, there is weak evidence on how these 
GWAS findings improve our understanding of the molec-
ular pathways that are involved in diseases and complex 
traits, thus bringing challenges to post-GWAS for the 
characterization of the molecular data [1]. Such associa-
tion patterns are deduced from beyond the genome to 
the functome scale. Since two or more high-throughput 
omics (HTO) technologies (genomics, epigenomics, tran-
scriptomics, proteomics, metabolomics, metagenomics 
and even beyond) can potentially be applied to the same 
animal or to biological samples from the same animal, it 
is important to assess how these diverse datasets at dif-
ferent biological levels can be integrated to exploit the 
full potential of such information for a holistic improve-
ment of production performance, disease resistance and 
welfare in animals. It will also be interesting to see how 
such HTO technologies may be used in a specific omics 
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assay [2]. The biology of systems has been meaningfully 
connected to today’s genetics of systems, appropriately 
termed ‘systems genetics’ or ‘systems genomics’ [3] in the 
context of animal breeding. In this process, researchers 
have been successful in defining the terms from ‘omes’ 
to the suffix ‘logy’ by positively exploiting our knowl-
edge (Table  1). ‘Systems genetics’ or ‘systems genomics’ 
approaches [3, 4] study complex traits that are measured 
using ‘omic’ technologies such as genome/exome arrays, 
gene expression arrays, mass spectrometry and next-
generation sequencing (NGS). These technologies are 
applied to study genomes, transcriptomes, epigenomes 
or methylomes and to link variations in these internal 
or ‘endo-phenotypes’ to external or ‘ecto-phenotypes’. 
Systems genetics discusses a branch of systems biology 
that integrates ‘omics’ scale data and uses them to iden-
tify causal genes and networks, regulatory genes and net-
works and predictive markers for complex traits.
Recently, a few articles reviewed systems biology and 
systems genetics in an animal context [18–20]. From the 
animal organizational level to the individual components 
of the systems within animals, these papers have given an 
overview of ‘omics’-enabled components that are charac-
terized by vast amounts of data. Furthermore, a collec-
tion of papers presented at the symposium on systems 
biology in animals have attempted to bridge the gap and 
demonstrated that complex regulatory relationships exist 
among genotypes and phenotypes with an emphasis on 
the applicability of these integrative systems biology 
methods [21]. Integrating data in the multi-omic space is 
difficult and tedious because of the extremely large vol-
umes of data produced across several HTO platforms, 
primarily from NGS machines. Secondary datasets that 
are generated after quality control of the raw datasets 
are further analysed by bioinformatics and statistical 
methods to create tertiary datasets (quality-controlled 
final datasets) that in turn form the basis of input data to 
systems genomics analyses. There are a number of com-
prehensive repositories of data obtained from genomic, 
transcriptomic and phenomic resources that are specific 
to complex traits and may explain the effect of variants 
(single nucleotide polymorphisms (SNPs), insertions, 
deletions, copy number variations (CNV)) on these traits 
[22]. Studies have validated several developments that 
aim at combining biological findings and data obtained 
from various resources. Recently, a complete model 
that estimates effects of candidate genes responsible for 
diseases and of those that affect interactions was con-
ceptualized in the form of a ‘Genome <==> Phenome 
Superhighway’ (GPS) [23]. Genetic mapping (either link-
age or association) of internal or endo-phenotypes (e.g. 
based on gene expression or metabolite or protein lev-
els or quantitative trait loci (QTL) mapping [3, 4]) has 
generated a wealth of data and created a need for clas-
sifying, annotating, storing and analysing these data to 
understand their role in the genetic variation of these 
endo-phenotypes. More precisely, the ‘omic’ space that 
contains data on a trait will advance our understand-
ing of the functions that are associated with biochemi-
cal pathways and the interactions between macro- and 
micromolecules [18]. However, it is necessary to care-
fully quality control a wide array of HTO methods that 
generate multi-omics datasets to remove redundant and 
false-positive data. With redundancy of data represent-
ing a huge threat in terms of errors in data usage, sharing 
data in a common information space would reduce the 
amount of redundant data and the potential for error. It 
would also contribute to harmonize to a greater degree 
the standardization activities across different ‘omics’ 
data, a critical issue in view of the integration of data 
from these different sources [2]. Assuming that each of 
these HTO datasets can be quality controlled, the next 
logical step would be to assess how these diverse HTO 
datasets that represent different biological levels could be 
integrated and jointly analysed to exploit their full poten-
tial for the improvement of animal production, health 
and welfare. With the foregoing introduction to multi-
omic data integration and analysis methods, our main 
Table 1 Overview of the different ‘omic’ levels used in systems genomic analyses
Description References
Genome Complete collection of DNA, containing all the genetic information of an organism [5]
Epigenome Complete collection of changes to the DNA and histone proteins [6]
Transcriptome Complete collection of RNA molecules in a cell or collection of cells [7]
Proteome Complete collection of proteins in e.g. a cell, tissue, or organism [8]
Metabolome Complete collection of small-molecule chemicals (e.g. hormones) in e.g. a cell, tissue or organism [9–11]
Microbiome Complete collection of (genes of ) microbes in the organism [12]
Metagenome Complete collection of genetic material contained in an environmental sample [13]
Phenome Complete collection of phenotypic traits, affected by genomic and/or environmental factors in an organism [14, 15]
Functome Complete collection of functions described by all the complementary members in living organisms [16, 17]
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objectives in this mini-review are to outline current and 
emerging methods to generate main ‘omic’ data types 
and highlight some applications in animal and veterinary 
sciences. This paper focuses only on the main HTO data 
types in systems genomics (genomics, transcriptomics, 
epigenomics, metabolomics and proteomics). The last 
section of this paper re-introduces ‘systems genetics’ or 
‘systems genomics’ in an emerging multi-omics context 
and provides perspectives on how systems genomics can 
be used towards improving animal production, health 
and welfare.
Review
Animal genomics
For both humans and various animal species, the study 
of the “whole genome” goes back to the 1990s when the 
focus was on the identification of genetic variants using 
the GWAS approach, which is based on microarrays or 
chips with tens of thousands of SNPs. In a GWAS, each 
SNP is statistically tested for significance of association 
with the trait/phenotype of interest. In comparison with 
the wide variety of available human SNP chips, the num-
ber of SNPs on an animal SNP chip is much smaller, e.g. 
60 K for pig and chicken, 50 K for sheep and 777 K for 
cattle. In livestock genomics, many GWAS focussed on 
production and health traits. In 2015, Sharma et al. [24] 
reported an extensive review on GWAS performed in 
cattle, pigs, and chicken. For example, GWAS on female 
reproduction traits in tropically adapted beef cattle [25], 
feed efficiency traits in pigs [26, 27], body weight in broil-
ers [28] and obesity and metabolic diseases using the pig 
as a model [29] have been conducted. The advantage of 
performing GWAS in livestock species over humans is 
the availability of related animals and subsequent knowl-
edge about the pedigree, which greatly reduces the num-
ber of individuals needed to reach sufficient power to 
detect genetic variants associated with the trait of inter-
est. Furthermore, linkage disequilibrium (LD), which is 
much more extensive in the genome of animals than in 
the human genome and depends on relatedness between 
animals, has a positive influence on the required sample 
size. Animal breeding deals with such issues by using a 
mixed model that accounts for the population structure/
pedigree [30]. An important bioinformatics task is the 
annotation of the GWAS variants that explain a certain 
proportion of phenotypic variation and the prediction 
of functional properties, which serve to build ontology-
based functional networks based on many databases. 
Many web services have been created to meet the chal-
lenge, but most of them only work within the framework 
of human medical research. Recently, the Functional 
Annotation of ANimal Genomes (FAANG) International 
Project Consortium was launched (http://www.faang.
org/), to bring together animal scientists and sustain a 
steady focus on collaborations among this community. 
Three of four committees in this FAANG consortium 
address key issues on the functional annotation of animal 
genomes based on contributions from researchers world-
wide, i.e. the Animals, Samples and Assays (ASA), Bioin-
formatics and Data Analysis (B&DA) and Metadata and 
Data Sharing (M&DS) committees. In addition, the 1000 
Bull Genomes Project has provided the bovine research 
community with a huge volume of data on bovine vari-
ants that will be useful for GWAS and the identification 
of causal mutations (http://1000bullgenomes.com). These 
initiatives pave the way for a systematic incorporation of 
the findings of systems biology and systems genetics and 
for making them available online.
Another very important revolution in animal breed-
ing is genomic selection (GS), a form of marker-assisted 
selection in which the whole genome (SNPs) is used in 
combination with the pedigree to predict breeding values 
of animals in a certain population (reviewed in [31]). GS 
or genomic prediction in general consists of two stages. 
First, the effects of SNPs are estimated using a training 
population for which both phenotypic and genomic data 
are available. Second, the effects of known SNPs are used 
to predict breeding values for a population for which 
only genomic data are available. The genomic best linear 
unbiased prediction (GBLUP) method uses a genomic 
relationship matrix (GRM) that describes the relation-
ship between genotyped individuals using whole-genome 
genotyping data and after standardizing the matrix with 
respect to allele frequencies, it behaves like the numera-
tor relationship matrix A in a regular BLUP. GBLUP 
provides genomic estimated breeding values (GEBV) of 
animals. This GBLUP version has evolved into single-step 
methods (ssBLUP) also known as the HBLUP method, 
as for example in the studies of Legarra et al. [32], Chris-
tensen et al. [33], Meuwissen et al. [31], and Koivula et al. 
[34] that calculate GEBV by using both the GRM and 
regular A matrix for both genotyped and non-genotyped 
animals. There are several GS methods, but the most 
widely used are those based on GBLUP and ssBLUP due 
to the simplicity of their assumptions and ease of compu-
tation. Bayesian methods that assume different distribu-
tional properties of SNP effects and a finite proportion of 
SNPs with non-zero effects are popular to identify QTL/
candidate genes in a mixed model set up. GS has huge 
advantages for livestock genomics, since it significantly 
reduces the generation interval and thereby increases the 
response to selection. Furthermore, traits that are dif-
ficult or even impossible to measure (e.g. milk produc-
tion on bulls or carcass traits on live animals) can now be 
genetically predicted and used to improve breeding strat-
egies. GS is currently extensively used, for example in the 
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pig [35] and cattle industries [36]. Recently, the expected 
potential of sequence-assisted selection was shown to be 
unrealistic, since the increase in accuracy reached with 
sequence-based genotyping was small compared to high-
density genotyping [37]. However, increased awareness 
about including quantitative trait nucleotide (QTN) or 
loci (QTL) has raised interest, because current GS meth-
ods still ignore the functional or biological relevance of 
genes and their associations with QTN and QTL, and 
only use genomic data to build genomic relationship 
matrices (GRM) between genotyped and non-genotyped 
relatives. Attempts have been made to evaluate the rela-
tive contribution of groups of SNPs to the total genetic 
variance of traits, such as, intronic, exonic, intergenic, 
synonymous or non-synonymous variant classes, and 
overall, it seems that there are no significant differences 
between different groups of SNPs, as shown by Do et al. 
[38]. Bayesian methods such as Bayes Cpi and Bayes R 
tend to provide more accurate predictions than GBLUP-
based methods when a trait is clearly affected by major 
QTL. The concept of the systems genomic BLUP (sgB-
LUP) method [4] is based on a mixture model for whole-
genome-based prediction and selection. sgBLUP uses 
two types of SNPs, i.e. SNPs that are functionally anno-
tated to be relevant for the specific trait in question (e.g. 
by GWAS and post-GWAS SNP annotation software) 
and SNPs called “residual SNPs” that are commonly used 
to build the GRM and can be used across all traits.
Emerging technologies in genomics and epigenomics
Technology in the genomic and epigenomic fields is 
developing fast and provides opportunities for new ways 
of investigating the genome or epigenome and further 
implementation in animal breeding methods. With the 
growing power and speed of NGS, genome-wide genetic 
variation is now captured at the DNA sequence level at 
tens of millions of genomic locations. Epigenetic vari-
ation also contributes to phenotypic variation through 
histone modifications and DNA methylation at the gene 
level, which can lead to changes in or absence of the 
expression of genes that underlie a phenotype or a dis-
ease. The technical features of NGS are rapidly evolving, 
i.e. for example, restriction-site-associated DNA sequenc-
ing (RAD-Seq), which was recently applied in chickens 
and showed the effectiveness of NGS for animal breeding 
issues [39]. Such data generated by these newest technol-
ogies will contribute to the identification of (novel) causal 
or regulatory variants, precise genome-wide LD patterns, 
and insertion-deletion (InDel) markers that will be useful 
in molecular-based animal breeding programs. Genotype-
by-sequencing (GBS) is another novel NGS technique 
that was developed for plant breeding, but has potential 
for animal breeding due to its cost-effectiveness [40, 41]. 
However, its potential to reach reasonable prediction 
accuracy and minimal bias depends on the sequencing 
depth and the number of individuals that are sequenced 
with GBS [41]. Similarly, CNV analysis using NGS has a 
significant impact on the study of phenotypic variation. A 
paradigm shift has occurred in such CNV studies with the 
initial global characterization being extended to in-depth 
studies leading to an integrated map. Although such 
enrichment analyses rely on good simulation and bioin-
formatics analyses, the results will produce a plethora of 
animal data that will contribute to the study of human 
diseases [42]. To ensure appropriate gene expression in 
animals, it is necessary to determine the frequency with 
which semi-methylated CpG islands (CGI) or sites exist 
in various animal tissues, which is now possible with 
genome-wide DNA methylation analyses. By combin-
ing different technical approaches used to produce NGS 
data, it is possible to analyse genome-wide methylation 
patterns and profiles that match at the single-nucleotide 
resolution [43]. One such method is reduced represen-
tation bisulfite sequencing (RRBS) [44], which is cost-
effective since it allows to sequence only about 1 % of the 
genome by combining restriction enzymes and bisulfite 
sequencing. Chromatin immunoprecipitation (ChIP) 
coupled with high-throughput sequencing is used to inte-
grate and efficiently identify protein-DNA binding sites 
in  vivo. Combining ChIP-Seq data with expression data 
will allow us to unravel genome-wide patterns and to 
capture regulons and regulatory networks. Furthermore, 
recently it has become possible to perform ChIP-Seq with 
small amounts of fixed animal tissues instead of cultured 
cells, which will allow systematic analyses of protein–pro-
tein interactions (PPI) networks [45]. In addition, dual 
luminescence-based co-immunoprecipitation (DULIP) 
makes it possible to detect PPI with high specificity and 
sensitivity. The co-immunoprecipitated luciferase tags are 
obtained either from ChIP-Seq methods or from other 
assays such as DULIP and further used to support and 
comprehend protein function and complex biological pro-
cesses [46]. With such advancements, systems-wide anal-
yses that integrate mutation-dependent binding patterns 
(protein or DNA) will become feasible. It will be interest-
ing to see how these methods improve the identification 
of candidate genes, drug targets and biomarkers as well as 
the capture of the complete genetic and epigenetic vari-
ation to accurately predict phenotypes. Currently, these 
high-throughput technologies offer many opportunities 
to better understand the complex quantitative traits and 
underlying (systems) biology. The remaining challenge 
is to overcome the difficulties in the discovery of causal 
genes and variants, drug targets, vaccines and biomark-
ers for highly complex diseases and traits of agricultural 
interest.
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Animal transcriptomics
Transcriptomic research investigates the expression lev-
els of all gene transcripts in a particular cell, at a par-
ticular time, and in a particular state. Up-regulation and 
down-regulation of genes result in different levels of pro-
teins and metabolites that induce phenotypic changes in 
the animal. Thus, a better understanding of the regulation 
of genes should provide insight into the biological func-
tioning and detection of genes that are important in dis-
eases or production traits. The most common approach 
to analyze expression data is to compare expression levels 
between two states, e.g. healthy versus diseased or high-
productive versus low-productive animals, also called 
differential expression analysis [47]. Several studies have 
focussed on the detection of differentially expressed (DE) 
genes for various production and health traits in differ-
ent species, for example adiposity in broilers [48], muscle 
development in cattle [49], skeletal muscle development 
in pigs [50] and intestinal parasite resistance in sheep 
[51]. Experiments on animals are done under controlled 
conditions and allow their dissection for the collection 
of various tissue samples, such as brain tissues, which is 
rarely possible in human studies. For example, Band et al. 
[52] reported a bovine genomics project that studied 
expression data from spleen, placenta and brain tissue for 
a large group of animals. Expression studies on different 
tissues may lead to a better understanding of the patho-
physiology of health and production traits in livestock.
Besides DE analyses, transcriptomic studies analyze 
gene–gene interactions by using a network approach that 
focuses on the detection of clusters of co-regulated genes. 
A popular method is the weighted gene co-expression 
network analysis (WGCNA) [53] which is implemented 
in an R-package. It detects the co-expression of genes 
using Pearson’s correlation and calculates the topologi-
cal overlap measure (TOM) that represents the number 
of shared neighbouring genes across gene pairs. Based 
on this measure, genes are clustered and the clusters are 
further linked to phenotypic data to reveal the important 
pathways that are involved in the biological background 
of the trait under study. Several livestock transcriptomic 
studies have used this approach to elucidate the genetic 
and biological background of health and production 
traits. In sheep, numerous pathways were detected in 
relation to muscling [54] and intestinal parasite resist-
ance [51]. In pigs, pathways and genes that affect mus-
cle and meat quality were identified [55] and in Hanwoo 
(Korean) cattle, genes related to intramuscular fat (mar-
bling) were detected [56].
Emerging technologies in transcriptomics
Following the trend in human research, transcrip-
tomic studies that are carried out on livestock species 
are making a shift from microarray expression data to 
RNA-sequencing (RNA-Seq) data and providing new 
opportunities to detect novel transcripts and genetic 
variants. With RNA-Seq, we now have the possibility 
of identifying and quantifying: isoforms, exon-specific 
expression, allele-specific expression and haplotype-
specific expression. A comparison of RNA-Seq data 
with microarray data and its advantages are discussed 
in detail by Malone and Oliver [57]. Nookaew et  al. 
[58] performed such a comparison using real expres-
sion data in Saccharomyces cerevisiae from both types 
of platforms and showed that findings based on micro-
array and RNA-Seq technologies were consistent. As 
in microarray studies, the most commonly applied 
method is the detection of DE genes, as was done in 
cattle [59–61], horses [62] and pigs [63–65]. Results of 
DE analyses can be used in a systems biology approach, 
as reported by Lee et al. [66] who integrated DE results 
across tissues. Several other studies have taken a step 
forward by using a gene co-expression network (GCN) 
approach using RNA-Seq. In Nellore cattle, a first study 
detected eight DE genes for feed efficiency [67], while 
a second study applied WGCNA to unravel the genetic 
architecture of feed efficiency [68] and showed that co-
expressed (CE) genes were mainly related to insulin 
responses and lipid metabolism. These findings com-
bined with data from histopathological analyses of the 
liver revealed that low feed efficient animals had a larger 
number of liver lesions than high feed efficient animals. 
A similar project is being conducted using different 
cattle breeds (Holstein and Jersey cows) with extreme 
feed efficiency phenotypes [69]. A gene co-expression 
network (GCN) approach was applied to pigs to detect 
co-expressed clusters of genes related to, for example, 
backfat androstenone phenotype [70], Salmonella shed-
ding [71] and obesity-related genes [72].
Animal reproduction through assisted reproductive 
technologies, such as in  vitro production of embryos 
(IVEP) combined with genomic selection, can result in 
rapid genetic improvement [73]. Transcriptomic and sys-
tems biology investigations on oocytes and embryo traits 
related to IVP, embryo transfer and subsequent preg-
nancy rates have detected biomarkers for successful IVP, 
embryo transfer and pregnancy rates [74–76].
In pig production, one of the challenges is to reduce 
boar taint i.e. an offensive taste or odour of the pork 
emitted during cooking, which makes it unpleasant for 
consumers. It is caused primarily by two compounds 
i.e. androstenone produced in the testicles and skatole 
produced in the hindgut. Both compounds accumu-
late mainly in the back fat of intact males and the only 
way to reduce boar taint is by surgical castration. How-
ever, surgical castration raises serious pig welfare issues 
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that contributed to a voluntary ban on surgical castra-
tion in Europe to avoid boar taint (http://boars2018.
com/). Heritabilities of androstenone and skatole levels 
are moderate to high [77], which indicates that breed-
ing for low boar taint in males has good potential and 
may resolve welfare issues in the long-run, since intact 
males could then be used in the food chain. GWAS 
has detected several genomic regions associated with 
androstenone and skatole levels [77–79]. It was shown 
that boar taint is not significantly correlated with 
growth traits and litter size [80, 81] and is even favoura-
bly correlated with male fertility [81]. Recent studies on 
RNA-Seq transcriptome profiling of pigs with high or 
low boar taint showed that there are key differences in 
the expression profiles of some genes [70, 82]. Follow-
ing this, our studies now focus on RNA-Seq transcrip-
tomics and systems biology of boar taint in Danish pigs, 
to identify DE and CE genes and build GCN to improve 
pig meat production in Denmark [83]. To gain more 
insight into the regulatory architecture of a particular 
trait or disease, several approaches can be combined or 
integrated to elucidate gene–gene interactions.
Another relatively novel and promising method is sin-
gle-cell transcriptome analysis, giving a deep-sequenc-
ing insight into the cell’s gene transcription [84]. This 
deeper insight can lead to a better understanding of the 
link between genome and phenome studies, and has 
potential mainly in cell development research (e.g. stem 
cell research) and in  situations where the collection of 
biopsy samples in sufficient numbers for RNA-Seq tran-
scriptomics is difficult (e.g. in the case of embryo biop-
sies before embryo transfer to donor cattle). Although 
a wide range of candidate genes and transcripts using 
RNA-Seq analyses can be exploited, the major challenge 
is to identify true positives. Methods based on map-
ping and genome assemblies might miss some candidate 
genes, if appropriate filtering techniques are not used. 
Another challenge is to quantify G/C blocks, paral-
ogons, isochores, 5′UTR regions, expression specific to 
splice variants, exon-specific and allele-specific expres-
sion. Transcriptomics studies based on RNA-Seq enable 
the study of non-coding RNAs but how such studies 
on non-coding RNAs can be used for systems genom-
ics approaches remains to be explored. In the last few 
years, there have been increasing efforts to sequence 
small RNAs including miRNAs. Since the initial appli-
cation of RNA-Seq, quantifying small RNAs, ascertain-
ing alternate splicing events, transcription start sites 
(TSS) and mapping strand-specific genes [85] have ben-
efited from such techniques. Many studies are under-
way to provide rigorous strategies for miRNA-Seq and 
other small RNA measurements, but this is beyond the 
scope of this review.
Animal metabolomics and proteomics
Proteomics aims at describing the complete repertoire 
of proteins in an organism [8], while metabolomics (or 
metabonomics) is the study of global metabolite profiles 
in living systems [11]. Although the use of both terms 
metabolomics and metabonomics is still debated, analysis 
of the metabolome is a challenging task since it considers 
all the metabolites, regardless of their chemical nature, 
i.e. amino acids, antibodies, aptamers, small biomol-
ecules, etc. and provides coherent gene expression data 
in an integrated manner. Metabolomics serves not only 
as a source of qualitative but also quantitative data on 
intracellular metabolites that are essential for the model-
based description of the metabolic network operating 
under in  vivo conditions. In recent years, several stud-
ies in livestock have investigated the metabolome, and 
metabolite profiling studies are now a rapidly expanding 
area in animal and veterinary genomics. Metabolomics 
tools aim at filling the gap between genotype and pheno-
type by permitting the simultaneous monitoring of mol-
ecules in a living system. Such metabolic information has 
applications in clinical practice, in the discovery of bio-
markers that are linked to cellular integrity, cell and tis-
sue homeostasis resulting from cell damage or death [86], 
and in metabolic engineering to optimize microorgan-
isms for biotechnology.
In dairy cattle, numerous potential biomarkers were 
detected for milk production and quality by studying the 
metabolome of different body fluids [87]. Likewise, in 
chickens, several potential biomarkers were identified for 
the ascites syndrome by investigating the liver metabo-
lome [88]. Another potential of metabolomics is the pre-
diction of phenotypes that are of economic interest, as 
was reported for pigs [89].
Emerging technologies in proteomics and metabolomics
Proteomic and metabolomic datasets provide vast 
amounts of multi-dimensional data points that need to be 
carefully quality-controlled, analysed and interpreted. As 
in genomics and transcriptomics, there are a wide variety 
of publicly available databases and tools for storing, que-
rying, browsing, analysing and visualizing metabolomic 
networks. For example, the PathCase Metabolomics Anal-
ysis Workbench (PathCaseMAW: http://nashua.case.edu/
PathwaysMAW/Web/) runs on a manually created generic 
mammalian metabolic network. The mapping of protein–
protein interactions (PPI) networks to phenotype and dis-
ease pathways is a key to understanding various biological 
and patho-physiological processes. Such interaction stud-
ies can be combined with studies on the conservation of 
non-coding RNAs across large evolutionary distances 
and on their potential functions in mammalian genomes 
i.e. [90]. Overall, ecosystems that are revealed by such 
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association networks, assemblies and interaction studies 
are challenged by various environmental conditions. In 
this process, a new field has emerged termed “synecology” 
that deals with the interactions of groups of organisms 
with their abiotic and biotic environments and is driven by 
the advances of the meta-omics methods using bioinfor-
matics-centred approaches [17]. This could lead to a new 
“omics” term i.e. synecomics defined as molecular systems 
synecology, which will contribute to understand not only 
the mammalian or animal dynamics, but also the micro-
bial processes that rely on systems-level responses.
Recently, many structural proteomics initiatives were 
launched to ascertain biochemical and cellular functions 
and have allowed the design of drugs at the molecular 
level [91]. The methods used include advances in hard-
ware design, data acquisition methods, sample prepa-
ration and further automation of data analysis. With 
40  to  50  % of the identified genes corresponding to 
proteins of unknown function, a functional annotation 
screening technology using nuclear magnetic resonance 
(NMR) (FAST-NMR) was developed to assign a bio-
logical function. These methods assume that a biologi-
cal function can be described based on the similarities 
between binding regions among proteins and that a given 
ligand interacts with a targeted sequence. The resulting 
structural and functional assignment to a protein can 
provide a starting point for the discovery of drugs as 
well as functional clues for regions that are regulatory or 
non-regulatory [91]. Nevertheless, functional proteom-
ics/metabolomics has evolved as the necessary next step 
for which NMR spectroscopy is used to study the func-
tions of a large repertoire of sequences that cannot be 
inferred based on the current methods for the detection 
of sequence homologies alone. Moreover, three-dimen-
sional structures of proteins/metabolites contribute 
greatly to inferring molecular functions (physical and 
chemical function). We can foresee that systems genom-
ics in the future will embrace large-scale proteomics/
metabolomics as an additional layer to provide connec-
tions with phenotypic variations.
Functional annotation and pathway analyses
In the preceding sections, we discuss individual ‘omics’ 
platforms and datasets with regards to their current sta-
tus and emerging trends. Regardless of which ‘omics’ plat-
forms are used, the Gene Ontology (GO) annotation is the 
most important and valuable means of assigning functional 
information using standardized vocabulary. Several com-
putational methods and tools are available for functional 
annotation across all species. Gene-based annotation 
can identify whether SNPs or CNV cause protein coding 
changes. For this purpose, gene definition systems such as 
RefSeq genes, UCSC genes, ENSEMBL genes, GENCODE 
genes are used. Genomic region-based annotation identi-
fies variants in specific genomic regions, for example, con-
served regions, NGS-based DE/CE regions, transcription 
factor binding sites, GWAS regions, etc. Although simi-
larity-based GO annotation is widely applied, it primarily 
encompasses sequence data with reciprocal best hits to 
predict candidates from a huge repertoire of multi-omics 
data. However, some of the orthologues of these sequences 
do not remain associated to GO terms and can be cross-
validated with conserved domains, manually reviewed 
data or determined by wet lab experiments, thus allowing 
the biological appropriateness of the functional assign-
ments. The unannotated regions in the form of hypo-
thetical proteins or “known unknowns” i.e. their existence 
is predicted but their function is not known, represent a 
huge problem, since they remain assigned to the three 
root terms as in the case of AMIGO (http://amigo.gene-
ontology.org/amigo). A few methods have been designed 
to integrate different structural and functional results with 
data corresponding to GO relationships of organisms [92]. 
In addition, the genome assemblies of many species are 
regularly refined and updated when new information is 
available. There has been an increase in the development 
of integrated analyses that provide comprehensive and 
robust GO annotations of genome assemblies, providing 
a solid foundation for functional interrogation of other 
genomes (http://www.ebi.ac.uk/GOA). Development of 
pathway maps and identification of unique and novel sig-
nals have transformed pathway association studies in cat-
tle [93]. Furthermore, Medical Subject Headings (MeSH, 
http://www.nlm.nih.gov/mesh) provides a comprehen-
sive life science vocabulary for human and model organ-
isms’ research. Multi-faceted ‘omics’ is aided by the choice 
of annotation and enrichment analyses for interpreting 
GO-aided MeSH functional terms. In summary, such GO 
annotations correspond to specific biological conditions or 
complex traits in specific species.
Pathway analysis can be described as “a group of sta-
tistical methods that exploit a priori knowledge of path-
ways” [94]. It forms the link between ‘omics’ results 
and the phenotype/disease under study and provides a 
biological meaning to the genes and variants detected 
(interpretation of results). Furthermore, it reduces the 
multiple-testing burden and, thus, offers a huge analy-
sis potential. Aslibekyan et  al. [94] showed that in spite 
of the great potential of pathway analysis, there are still 
many obstacles to overcome (for example, due to the lack 
of a golden analysis standard).
Emerging technologies in pathway profiling and genetic 
networks
In spite of the multidimensional HTO efforts to under-
stand phenotypic variation, there remains a major 
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scientific bottleneck regarding the inference of contex-
tual pathways that underlie the translation from variation 
in biological systems to phenotypic variation. Recently, 
some integration models that address the characteriza-
tion of the interaction between functional modules have 
been reported [95]. For example, the PAthway Network 
Analysis approach (PANA) integrates high-throughput 
data and their functional annotation using machine-
learning methods [96]. The end-user can detect the func-
tional modules that are associated within the molecular 
system and the transcriptional connections in a disease 
or a phenotype. Molecular systems biology integrates 
networks in the form of pathways, interactions and/
or associations. Associations are inferred only as links 
within the relationships, whereas physical relationships 
in the form of pull-down assays or biochemical experi-
ments are inferred as interactions. Nevertheless, the 
paradigm that all interactions are associations but not all 
associations are interactions can be widely applied across 
all functional modules. As discussed previously, keep-
ing in view the various biochemical pathways and reac-
tions, the models aim at analysing and measuring the 
quantity of molecules that are present within a cell [20]. 
However, the models used depend on the type of assay, 
on how epigenetic modifications are deduced from the 
transcriptomic data, on whether or not the disease risk 
is considered, and on the type of genetic heterogeneity 
investigated in relation to the phenotypic trait [97, 98].
Many studies have shown the importance of genetic 
interactions, especially in the determination of complex 
polygenic traits [99–101], which support the great poten-
tial for network genetics. In general, a GWAS investigates 
the genome of different individuals to detect variants 
that are associated with a trait, but it does not take the 
interactions between loci into account. However, studies 
on genome-wide interactions among SNPs for specific 
traits are being carried out, see for example, a paper on 
carcass-related traits in Brahman cattle [102]. One fur-
ther step is to include epistatic interactions in a network 
approach, for example using the weighted interaction 
SNP hub (WISH) network method [103], which has been 
successfully applied to a pig resource population to detect 
genes and pathways related to human obesity [29]. This 
method pre-selects SNPs based on their genome-wide 
significance by setting a much lower significance level 
than in standard GWAS, and subsequent calculation of 
the epistatic interaction effects between all SNPs is used 
in a clustering approach. Another promising method is 
the association weight matrix (AWM) approach, which 
combines data from several GWAS by looking at interac-
tions between SNPs based on the sizes of their estimated 
additive effect [104]. This method has successfully iden-
tified genes and pathways for growth in cattle [105] and 
puberty in tropical cattle breeds [106]. The latest reports 
show how lncRNAs contribute to regulatory interac-
tions with their non-coding peers such as miRNAs [107]. 
Whether lncRNA-protein networks restrain interactions 
is not clearly known. How such regulatory interactions 
between classes of lncRNAs and proteins can have a sig-
nificant influence on an organism is a focus of interest. 
Recently, our group reported the detection of one such 
lncRNA-protein association that was consistent with 
interaction networks built from RNA-Seq data [108]. 
These studies will allow us to understand how such asso-
ciation networks contribute to transcriptional regula-
tion in various organelles. In addition, applying network 
methods and pathway analyses to genes that are related 
to a wide range of diseases and phenotypes will allow 
researchers to gain deeper insight into pathophysiologi-
cal and biological processes.
Multi‑omic data from genome to phenome: integration 
in systems genomics
The term ‘systems genetics’ or ‘systems genomics’ in an 
animal breeding context was originally proposed by 
Kadarmideen et  al. [3], but there are recent reviews on 
this topic with applications in humans [109] as well as 
in animals [4]. As thoroughly discussed in these articles, 
systems genetics/genomics focuses on the integration 
of different ‘omics’ levels. This includes a wide range of 
approaches, from relating the individual’s ‘omics’ levels 
with functional annotation, both on a single gene level 
and pathway analysis level, to integrating all different 
multi-omic levels to phenotypes. A typical data integra-
tion process goes from genome →  epigenome →  tran-
scriptome → metabolome → proteome → phenotype or 
disease variome.
The integration of data related to protein abundance/
mRNA expression using regulatory networks has been 
investigated with respect to gene expression involved in 
bovine puberty [110]. Integration of genomic and tran-
scriptomic data, for example using the expression quan-
titative trait loci (eQTL) approach, detects regions in the 
genome that are associated with transcript levels [111]. 
These eQTL can be cis- or trans-acting: a cis-acting eQTL 
is located near the gene that encodes the transcript, while 
a trans-acting eQTL is located at quite a distance or even 
on another chromosome. Several studies in pig have 
incorporated this approach to detect candidate genes, for 
example for muscle characteristics [112–114] and obesity 
phenotypes [115]. A recent multi-parental population 
study on heterogeneous stocks (HS) in rats, mice and 
humans identified targeted candidate genes and mapped 
them to disease phenotypes [116]. In this work, the 
authors applied differential expression analysis followed 
by eQTL analysis, and then using a mixed-model analysis 
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based on the sequence of the founder animal, they identi-
fied variants within the detected region. Although such 
studies can detect variants within disease-causing genes, 
whether or not these causal genes alone may play a role 
in these complex phenotypes remains a challenge. Ques-
tions remain such as: (1) how important these eQTL are 
for the study of genetic networks that underlie pheno-
typic variation? (2) Can these eQTL data generated from 
transcriptomics analyses be linked to the proteomics 
level? Although transcriptomic and phenomic data may 
appear uncorrelated, mapping genetic determinants of 
gene expression (eQTL) can provide a remarkable frame-
work for understanding large phenotypic effects and link-
ing genetic variants to disease [117].
Clustered regularly interspaced short palindromic 
repeats (abbreviated as CRISPR) in combination with 
Cas9 protein (CRISPR/Cas) systems guide RNAs into 
a cell’s genome (the nuclease) and cut the genome at 
desired locations (this technique is often referred to as 
genome-editing). Since it was first introduced by Cong 
et al. [118], many site-directed mutagenesis experiments 
have been carried out across various tissues, large ani-
mal models and populations [119, 120]. This site-directed 
genome editing technology has extensively improved 
the precision at which genome modifications can be 
obtained compared to earlier transcription activator-
like effector nucleases and zinc-finger nucleases systems. 
To date, it has not been used extensively in animal and 
veterinary sciences, but it is clearly foreseen that animal 
genome modification using CRISPR/Cas systems will 
play a key role in improving disease resistance or trait 
performances in animals or to create “designer animals” 
such as transgenic animals. One other application is that 
once a causal gene/QTL is validated, it can be specifically 
edited by applying the CRISPR-Cas system. Such modi-
fications of the genetic architecture of an organism are 
only just beginning and have not been adequately studied 
in animals. A recent paper on human albumin produced 
in pigs through CRISPR/Cas9-mediated knockin of 
human cDNA into the swine albumin locus at the zygotic 
level illustrates the potential of this technology for animal 
research [121]. The use of RNA-Seq transcriptomic stud-
ies to infer CRISPR-mediated systems should play a cru-
cial role in advancing this technology even further.
Animal systems genomics is still far from fully exploit-
ing the power of deep NGS. For instance, RNAseq can 
provide not only accurate measures of gene expression 
levels but also data on isoforms, exon-specific expres-
sion, allele-specific expression and haplotype-specific 
expression. The benefits of RNA-Seq in systems genom-
ics studies are yet to be fully exploited, for instance, in 
eQTL studies. Wang et al. [122] reported the use of the 
Lyon hypertensive (LH) rat bred for high blood pressure 
in eQTL mapping by taking advantage of RNA-Seq data. 
To what extent these additional benefits of RNA-Seq can 
be integrated in eQTL studies are still unknown but we 
can foresee the emergence of eQTL studies that will use 
this information in integrative systems genomics studies.
During the last decade, strategies to detect metabolic 
QTL have emerged and are based on the characteriza-
tion of metabolites and small molecules using large-scale 
analytical methods. Such methods allow researchers to 
better understand the biochemical pathways that span a 
metabolic network. Whether or not the environment has 
an impact on the metabolism can be analyzed by using a 
phenotypic state of the metabolism called a “metabotype”. 
This metabolomic/metabotype quantitative trait locus 
(mQTL) mapping and metabolomic genome-wide asso-
ciation studies (mGWAS) have been widely applied to 
derive information from genetic polymorphism stud-
ies, see for example, a human study of cardiovascular 
diseases [123]. However, a comprehensive framework 
to understand this multi-omic convergence of high-res-
olution metabolomics is lacking such as that developed 
in the R-package mQTL.NMR for an integrative analyti-
cal framework for genomic and metabolomic profiles to 
characterise mixed systems [124]. The principle of mQTL 
or mGWAS can be also applied to a list of known metab-
olites (e.g. low-throughput metabolite profiles consist-
ing of up to 200 compounds) that are assumed to affect 
a given disease phenotype in animals. For instance, Pant 
et  al. [125] identified several QTL that influence a large 
range of metabolites affecting obesity and obesity-related 
phenotypes via combined linkage disequilibrium linkage 
analysis (LDLA) in F2 crossbred pigs, and subsequently, 
investigated the human chromosomal regions that were 
syntenic to these identified mQTL. Further discussion on 
this work is beyond the scope of this review, but clearly 
quality control and analyses of large-scale metabolic/
metabolomic phenotype data represent a big challenge 
for animal genetic studies [126, 127]. Another novel area 
of research is the mapping of genetic variants that affect 
protein abundance (pQTL), which to date has been suc-
cessfully applied on an F2 mouse population [128] and for 
the analysis of cellular responses to chemotherapy [129]. 
Such developments provide great opportunities to iden-
tify biomarkers for animal disease and production traits. 
Regardless of what type of QTL or SNP is detected for 
animal traits (eQTL, mQTL, pQTL), they can be incor-
porated into models that aim at understanding/detecting 
causal and regulatory loci in the genome, as discussed in 
[109] and [4].
Figure  1 summarizes the preceding discussions on 
multi-omic data integration and systems genomics. It 
illustrates how multi-omic data are generated and inte-
grated by various HTO platforms from the genome level 
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through various ‘omes’ to the animal phenotype or dis-
ease variome databases. It shows individual, single-layer 
‘omic’ analyses as well as multi-layer ‘omic’ analyses in 
a systems genomics framework. Typical results from 
single-layer genomic or transcriptomic analyses can be 
visualized in terms of GWAS—Manhattan plots, vari-
ant calling plots from NGS data, transcript counts from 
RNA-Seq transcriptome data, genome-wide epistasis 
heat maps, and differential expression heat maps, etc. 
With a given HTO dataset from one of the ‘omics’ plat-
forms, single-layer specific analyses are carried out 
before merging a given HTO dataset with another HTO 
dataset. For instance, GWAS and differential or co-
expression (DE/CE) analyses are conducted indepen-
dently from each other before combining these HTO 
datasets to identify eQTL or eSNPs. This also applies to 
metabolite or metabolomic profiles (NMR peaks) that 
are affected by QTL or SNPs (mQTL or mSNPs). Con-
ducting an epigenetic study to identify differentially 
methylated regions and integrating these analyses and 
results with transcriptome analyses that are focused on 
DE/CE analyses is another example. Typical results from 
two- or multi-omic analyses include eQTL maps, eSNP 
effects, mQTL or mSNP effects, directed gene regulatory 
networks (using SNP data), PPI networks built by using 
multi-omic data as evidence, co-expression networks of 
genes that are mapped as cis- and trans-acting eQTL or 
those that are differentially expressed. Applications of 
these multi-omic data analyses include genomic predic-
tion/selection, use of functional, regulatory and causal 
Fig. 1 Overview of integrated genomics with various other ‘omics’ platforms/data types created via array-based or spectrometry or NGS technolo-
gies and systems genomics analyses. a Collection of multiple types of ‘omics’ datasets in farm or companion animals in controlled experimental 
conditions or in field experiments. b Systems genomics involves analysis of single-layer (vertical arrows) and multi-layer ‘omic’ datasets (horizontal 
arrow) ranging from GWAS, differential expression or methylation analyses through proteomic/metabolomic datasets to eQTL/mQTL/pQTL and net-
work analyses. c Typical results of systems genomics involve single- and multi-layer analyses from GWAS Manhattan plots, genome-wide epistatic 
heat plots, variant detection or transcript counts in NGS data and gene expression heat plots through eQTL maps, gene regulatory or co-expression 
networks of eQTL or protein–protein interaction (PPI) networks to networks of differentially connected genes. The eSNP/eQTL box plot is taken 
from Kogelman et al. [115]. The remaining images in this panel are from the authors’ own unpublished material. d Potential applications of such 
approaches involve identification of causal genes or pathways, biomarkers, drug targets, various networks for a specific trait level or disease state 
and individualized genomic predictions of performance or disease risk
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variants in developing highly accurate assays for disease 
prevention and diagnosis or holistic trait improvement. 
The use of epigenetic markers, metabolomic profiles 
or fingerprints, biomarkers and drug targets is highly 
appropriate for disease prognosis/diagnosis/treatments 
and clinical interventions in veterinary medicine and 
thus contributes to improving animal health and wel-
fare. Molecular pathways and annotation of variants can 
be used in disease diagnosis and phenotype improve-
ment. Systems genomics is typically characterized by 
several types of interaction or association networks and 
includes SNP-SNP, gene–gene, protein–protein, metab-
olite-metabolite networks that characterize a particular 
disease or healthy state or performance levels in animals. 
These networks provide deeper insights into interactions 
within and across tissues as well information on master 
regulatory genes or variants or metabolites or proteins 
(the ‘hubs’) that can be used as predictive markers in dis-
ease diagnosis and phenotype improvement.
Conclusions
In this review, we discuss the current and emerging tech-
nologies within the fields of genomics/epigenomics, tran-
scriptomics, metabolomics and proteomics, and provide 
some examples from livestock species. We re-introduce 
systems genetics/genomics in a “sequence-space” and 
multi-omic context with a focus on animal and veteri-
nary biosciences. Due to the enormous progress in (e.g. 
sequencing) technologies, data generation is becoming 
cheaper and easier, resulting in huge amounts of data 
at different ‘omics’ levels. In the last few decades, data 
were generated to elucidate the biological mechanisms 
that underlie animal production, health and welfare 
traits. This has led to great insight into mechanisms and 
detection of (potential) biomarkers and vaccines, and 
improved animal breeding strategies. We briefly men-
tion different existing and emerging ‘omic’ technologies 
and their implementation in livestock species (includ-
ing genomics, epigenomics, transcriptomics, metabo-
lomics and proteomics). The challenge that remains is to 
use all these ‘omics’-level data sets efficiently by remov-
ing errors/noise via good quality control methods for 
each layer of dataset, appropriate data integration as per 
the defined systems genomics hypothesis and statistical 
models, application of advanced statistical-bioinformatic 
algorithms and meaningful interpretation of results. 
The clear advantage of these integrative methods is to 
increase the power of detecting true causal genes, regu-
latory networks and pathways leading to improved ani-
mal health, welfare and/or production. Outcomes such 
as causal genes or variants (QTN or QTL), regulator 
genes, biomarkers and gene networks should be incorpo-
rated into genomic selection and breeding programs for 
larger impact. These prospects are becoming more feasi-
ble, as genomic selection methods tend more and more 
to include various types of QTL information in genomic 
prediction models. Through such extended, biologically 
and functionally meaningful and accurate genomic selec-
tion methods, improvement of animal production, health 
and welfare will be even faster and more sustainable.
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